Nanosphere To Present At UBS Global Life Sciences Conference

NORTHBROOK, Ill., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William Moffitt, Nanosphere's President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference taking place at the Grand Hyatt Hotel in New York City on Wednesday, September 19, 2012 at 8:30 a.m. ET.

About Nanosphere, Inc.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for detection of life threatening infections and cardiovascular diseases. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us .

The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344
CONTACT: Investors:         Nanosphere, Inc.         Roger Moody, 847-400-9021         Chief Financial Officer         rmoody@nanosphere.us                  Media:         The Torrenzano Group         Ed Orgon, 212-681-1700         ed@torrenzano.com

company logo

If you liked this article you might like

Insider Trading Alert - NSPH, SIGI And CFFI Traded By Insiders

Insider Trading Alert - NSP, CTXS And NSPH Traded By Insiders

Nanosphere (NSPH) Stock Surging as Luminex Ups Bid

Nanosphere (NSPH) Stock Skyrockets on $58 Million Luminex Deal

4 Stocks Under $10 Making Big Moves Higher